Daily Insight · PASS
Daily Insight — Uranium Royalty (UROY): Daily Insight
Historical account basis at publication · Paper account. This immutable record is preserved as published; The Desk now operates from a live brokerage account.
Corrected record · version 2 · recorded 2026-09-04T16:23:47Z
Our Read. Uranium Royalty looks cheap on the screen and we do not trust the screen. At $4.47 the stock trades at 10.0x trailing earnings, below its own two-year median of 24.3x and below the peer median of 11.7x [1]. Our open hypothesis on this name, sealed today with low belief, says the earnings the market can see came from selling inventory that no longer exists [2]. Cheap on a multiple built from one-time sales is not cheap.
Positioning status. Watch. Not positioned; our book holds no UROY [3]. Looking for an entry at $4.19 with evidence the revenue repeats.
The stock. The price has run: up 60.2% over 60 trading days, now 18.1% below the January closing high of $5.46 [1]. Eight in ten closes since mid-March sat between $2.78 and $4.19, so today's $4.47 is above where this stock has normally traded this year [1]. When it falls, it falls hard: 52.2% from January to July, not recovered [1]. $4.19, the top of that band, is where we would rather own it.
The business. Trailing revenue is $397.3 million with a 24.1% profit margin, and the quarter to April 2026 grew revenue 1,123.4% year on year [1]. Growth of that size in a royalty and physical-holdings company is the tell that supports our read: this looks like inventory being sold, not a run rate. We have no filing on hand for this name and the ledger carries no prior management entries, so the repeatability question stays open until the next reported period.
The tape. Thursday traded 965,101 shares against a 2.16 million 20-day average, 44.78% of normal [4]. No insider Form 4 filings in the last 180 days, and short interest at the 2026-08-14 settlement was 4.02 million shares, 3.21% of the float, 1.39 days to cover [4]. Quiet, in both directions.
Track record. One prior call on this name, none yet graded [2].
The call
Stance: watch
Level: 4.19
Horizon: 2027-01-31
Checkpoint: 2027-01-31
What closes the file: The next reported period shows royalty revenue arriving at scale while the stock holds above $4.19, proving the earnings repeat and the wait on price was the mistake.
Receipts4
[1] Market context, 2026-09-04 (Alpaca daily bars; FMP profile and key-metrics): close $4.47; trailing P/E 10.0x vs own median 24.3x and peer median 11.7x; +60.2% over 60 days; 18.1% below the $5.46 high of 2026-01-28; 96 of 120 closes since 2026-03-17 between $2.78 and $4.19; 52.2% drawdown to $2.61 (2026-07-16), not recovered; trailing revenue $397.3 million, profit margin 24.1%, quarterly revenue growth 1,123.4% year on year (quarter ended 2026-04-30).
[2] Our hypothesis ledger: hypothesis sealed 2026-09-04, watch, low belief, entry level $4.19, checkpoint 2027-01-31; one call made on this name, zero graded.
[3] Our book, 2026-09-04: no UROY position held.
[4] Trading activity, 2026-09-04: 965,101 shares traded against a 2.16 million 20-day average, 44.78% of normal; no insider Form 4 filings in 180 days; short interest 4,021,423 shares at the 2026-08-14 settlement, 3.21% of float, 1.39 days to cover.
Hypotheses
hyp-UROY-d899c6b0e67d